What is Gritstone Oncology Inc (GRTS) stock price today?

Gritstone Oncology Inc (GRTS) currently trades at $0.03 per share. The stock has a market capitalization of $3.80M and a P/E ratio of —x.

Is GRTS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Gritstone Oncology Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Gritstone Oncology Inc's revenue and earnings?

Gritstone Oncology Inc has trailing twelve-month (TTM) revenue of $14.61M with profit margins of 0.00%. Earnings per share (EPS) is $-1.09.

GRTS

Gritstone Oncology Inc

NASDAQ: GRTS · HEALTHCARE · BIOTECHNOLOGY

$0.03

+0.00% today

Updated 2026-04-30

Market cap

$3.80M

P/E ratio

—

P/S ratio

0.26x

EPS (TTM)

$-1.09

Dividend yield

—

52W range

$0 – $0

Volume

—

Market cap

$3.80M

P/E ratio

—

P/S ratio

0.26x

EPS (TTM)

$-1.09

Dividend yield

—

52W range

$0 – $0

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$1.00

+3005.59%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-26.84M

- Revenue declining -52.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$4.04M	$46.72M	$9.27M	$1.33M	$14.61M
Net income	$-104.61M	$-74.95M	$-113.13M	$-138.49M	$-23.40M
EPS	—	—	—	—	$-1.09
Free cash flow	$-92.62M	$-56.14M	$-121.82M	$-126.22M	$-26.84M
Profit margin	-2,591.31%	-160.44%	-1,220.49%	-10,404.96%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GRTS	$3.80M	34	2.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Gritstone Oncology Inc trades at $0.03. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $14.61M.

Frequently asked questions

What is Gritstone Oncology Inc's stock price?

Gritstone Oncology Inc (GRTS) trades at $0.03.

Is Gritstone Oncology Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Gritstone Oncology Inc (GRTS)?

The analyst target price is $1.00, representing +3005.6% upside from the current price of $0.03.

What is Gritstone Oncology Inc's revenue?

TTM revenue is $14.61M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.26x

ROE-201.90%

Beta0.50

50D MA$0.32

200D MA$1.01

Shares out0.12B

Float0.12B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GRTS vs LLY →GRTS vs JNJ →GRTS vs ABBV →Stock screener →